J a n u a r y 1 2 t h , 2 0 2 1

ICR Conference

Safe Harbor Disclosure

This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, EPS, and free cash flow; the Company's ability to adapt to and perform well in the current changing disrupted environment, including ensuring the health and safety of employees and maintain business continuity; anticipated inventory reductions; the Company's ability to have a disciplined capital allocation strategy, reduce debt and create value; the expected market share and consumption trends for the Company's brands; and the Company's disciplined capital allocation strategy. Words such as "trend," "continue," "will," "expect," "project," "anticipate," "likely," "estimate," "may," "should," "could," "would," and similar expressions identify forward-looking statements. Such forward-looking statements represent the Company's expectations and beliefs and involve a number of known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors include, among others, the impact of the COVID-19 pandemic, including on economic and business conditions, government actions, consumer trends, retail management initiatives, and disruptions to the distribution and supply chain; competitive pressures; unexpected costs or liabilities; the financial condition of the Company's suppliers and customers; and other risks set forth in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended March 31, 2020. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this presentation. Except to the extent required by applicable law, the Company undertakes no obligation to update any forward-looking statement contained in this presentation, whether as a result of new information, future events, or otherwise.

All adjusted GAAP numbers presented are footnoted and reconciled to their closest GAAP measurement in the attached reconciliation schedule or in our November 5, 2020 earnings release in the "About Non-GAAP Financial Measures" section.

I C R C o n f e r e n c e 2 0 2 1

Contents

  1. Introduction to Prestige Consumer Healthcare
  1. Brand Building in a Dynamic World
    III. Financial Profile & Capital Allocation
    IV. The Road Ahead

I C R C o n f e r e n c e 2 0 2 1

Introduction to Prestige Consumer Healthcare

Who We Are: Helping Consumers Care for Themselves

eye drops per year

throat drops for every cold season

doses of pain relief per week

infections treated annually

Source: Company records

I C R C o n f e r e n c e 2 0 2 1

Diversified Portfolio of Leading Consumer Healthcare Brands

Total Sales* by Category

Oral

Care

Dermatologicals

10%

Women's

Health

11%

26%

Eye &

12%

Ear Care

12%

18% GI

Cough /

12%

Cold

Analgesics

* FY'20 Revenues, Excludes Other OTC (less than 1%)

#1 Brands Represent Two-Thirds of Total Sales*

#1 Feminine Hygiene

#1 Vaginal Anti-Fungal

#1 Enemas & Suppositories

#1 Motion Sickness

#1 Powdered Analgesic

#1 Sore Throat Liquids/Lozenge

#1 Allergy & Redness Relief Drop

#1 Wart Removal

#1 Lice/Parasite Treatments

I C R C o n f e r e n c e 2 0 2 1

Proven, Consistent & Repeatable Strategy

Cash Generation

Capital Allocation Options

  • Positioned for long-term 2% to 3%(1) Organic growth
  • Brand building to drive long-term success
  • Industry-leadingfinancial profile
  • Consistent and strong FCF generation
  • Enables capital allocation opportunities
  • Disciplined capital allocation priorities
  • Prioritization of debt reduction & liquidity
  • Opportunistic share repurchases in FY20 & 1H21

I C R C o n f e r e n c e 2 0 2 1

Brand Building in a Dynamic World

Investment Across Key Brands Drives Organic Growth

Invest for Growth

Manage for Cash

Power Core

Core

International

Other OTC

50%

10%

10%

Sales Contribution to

Portfolio (Approximate %)

30%

# of Brands

5

11

18+

40+

Representative Brands

Long-Term Organic

3%+

1-3%

5%+

-4% to -8%

Growth Target

(approximate):

Long-Term 2% to 3% Sales Growth Target

I C R C o n f e r e n c e 2 0 2 1

Portfolio Positioned To Benefit From Changing Environment

Consumers Seeking Trusted Brands

Increased consumer focus on self-care and hygiene

Accelerated trend towards shopping online

Continuing to benefit from investments and diverse positioning

I C R C o n f e r e n c e 2 0 2 1

10

Playbook Remains Consistent in an Evolving Retail Environment

Retail Traffic Driver

  • Need-basedproducts sought by consumers, beginning a basket of purchases
  • Retailers dedicating more shelf space and focusto health & hygiene "self-care" product
  • We are retail channel agnostic; placement & content opportunities in e-commerce and other channels

Long-Term Brand Building Toolkit

  • Develop and understand consumer insights
  • Wide-rangingand flexible brand strategiesfocused on growing categories
  • Leverage long-standingbrand heritagewith focused digital and content marketing
  • New product and claim developmentthat are key to category growth
  • Channel developmentopportunities

Brand-Building Differentiates versus Private Label and Branded Competition

I C R C o n f e r e n c e 2 0 2 1

Nimble Marketing Efforts Balanced Against Long-Term Strategy

Long-Term Growth Toolkit Wide-Ranging

Professional

Marketing

Brand Innovation &

Extensions

Digital Marketing &

Content

Wide Channel

Availability

Real-Time Agile Marketing Strategy Across Portfolio

  • Engaging customers through campaigns both in-store and online
  • Investment in current initiatives leading to strong momentum
  • Consumer brand promise: Brighter, whiter, and more comfortable
  • New campaign across all key touchpoints

I C R C o n f e r e n c e 2 0 2 1

Winning in Consumer Shift to Online

eCommerce as a % Retail Sales

+122%

  • Growing eCommerce trend continued into Q2; eCommerce representing 10%+ of consumer retail sales in 1H
    • Robust growth across all eCommerce partners
  • Long-termfocus and heavy investment on eCommerce channel paying dividends
  • Many brands in portfolio hold market share at or above offline channels

Online Tools

Increase

Consumer

Conversion

Consumers Continue to Seek Treat at Home Remedies

I C R C o n f e r e n c e 2 0 2 1

13

Financial Profile and Capital Allocation

Cash Flow Drivers That Enable Capital Allocation

Key Attributes and Positioning

  • Net Debt at September 30 of ~$1.5 billion(3), leverage ratio of 4.3x(4)
    • Target leverage ratio(4) of between 3.5x and 5.0x
    • Ample liquidity; $100+ million in revolver capacity
  • Strong Free Cash Flow Generation
    • Portfolio characteristics drives solid EBITDA margins
    • Strong cash flow conversion (minimal capital expenditure outlays, low cash tax rate)
  • Target approximate mid-30s EBITDA margin over time

Capital Allocation Priorities Unchanged

1

Invest in Current Brands to Drive

Organic Growth

2

Continue Strategy of De-Leveraging

3

Opportunistic Share Repurchases

4

Pursue Accretive M&A that is

accretive for Shareholders

II C R C o n ff e rr e n c e 2 0 2 1

15

…and Best-in-Class Free Cash Flow Conversion

FCF

129%

125%

Conversion:

117%

11%

106%

106%

83%

83%

75%

8%

8%

8%

58%

FCF

5%

Yield:

4%

4%

4%

4%

4%

CHD

CL

CLX

PG

EPC

HELE

JNJ

ENR

Source:

FactSet data as of November 10, 2020; comparable set includes selected HPC companies

Note:

Free Cash Flow Conversion defined as Non-GAAP Operating Cash Flow less Capital Expenditures over Adjusted Net Income; Adj. Free Cash Flow Yield defined as Free Cash Flow divided by Market Cap as of November 10, 2020

I C R C o n f e r e n c e 2 0 2 1

Strong and Consistent Cash Flow Leads to Rapid De-Levering

Adjusted Free Cash Flow(3)

$165

$185

$197

$208

$202

$207

$127

$131

$67

FY 12

FY 13

FY 14

FY 15

FY 16

FY 17

FY 18

FY 19

FY 20

Leverage Ratio(4)

~5.0x

~4.3x

~4.3x

~5.2x

~5.0x

~5.7x

~5.2x

~5.0x

~4.7x

FY 12

FY 13

FY 14

FY 15*

FY 16

FY 17

FY 18

FY 19

FY 20

Dollar values in millions.

  • Peak leverage of 5.75x at close of the Insight Acquisition in September 2014

3.5x-5.0xlong-term target range

I C R C o n f e r e n c e 2 0 2 1

The Road Ahead

Strategy in Place for Value Creation

Long-Term Strategy

Business Continuity

Agile Marketing

Financial Profile &

Cash Flow

  • Brand-Buildingdesigned to grow categories and connect with consumers
  • Strategy and tactics performing well in disrupted environment
  • Continuity plans continue to protect service levels
  • Investing in inventory has paid off in challenged supply environment
  • Pivoted marketing efforts and returned to normalized investment levels
  • Benefited from investments in winning channels wherever consumers shop
  • Solid financial profile and cash flow generation
  • Continued focus on debt reduction in Q2

Strategic Priorities Remain Intact

I C R C o n f e r e n c e 2 0 2 1

19

Outlook: Staying the Strategic Course to Create Value

Top Line Trends

EPS

Free Cash Flow &

Allocation

  • Business and strategy remain well-positioned in changing environment
  • Market share solid and growing during pandemic environment
  • Anticipate FY 21 Reported Revenue of ~$925 million
    • Expect similar dollar performance to 1H; cough, cold, and travel remain under pressure
  • Anticipate FY 21 EPS(5) of ~$3.18
  • Strong financial profile leading to increased profitability
  • Anticipate FY 21 Free Cash Flow(6) at or above $207 million generated in FY 20
  • Continue to execute disciplined capital allocation strategy
  • Remain focused on debt reduction

I C R C o n f e r e n c e 2 0 2 1

20

Appendix

Appendix

  1. Organic Revenue is a Non-GAAP financial measure and is reconciled to the most closely related GAAP financial measure in the attached
    Reconciliation Schedules and / or our earnings release dated November 5, 2020 in the "About Non-GAAP Financial Measures" section.
  2. Total company consumption is based on domestic IRI multi-outlet + C-Store retail sales for the period ending October 4, 2020, retail sales from other 3rd parties for certain untracked channels in North America for leading retailers, Australia consumption based on IMS data, and other international net revenues as a proxy for consumption.
  3. Adjusted EPS, Adjusted Gross Margin, Adjusted Operating Income, EBITDA, EBITDA Margin, Free Cash Flow and Net Debt are Non-GAAP financial measures and are reconciled to their most closely related GAAP financial measures in the attached Reconciliation Schedules and / or in our earnings release dated November 5, 2020 in the "About Non-GAAP Financial Measures" section.
  4. Leverage ratio reflects net debt / covenant defined EBITDA.
  5. Adjusted EPS for FY 21 is a projected Non-GAAP financial measure, is reconciled to projected GAAP EPS in the attached Reconciliation Schedules and / or in our November 5, 2020 earnings release in the "About Non-GAAP Financial Measures" section and is calculated based on projected GAAP EPS plus adjustments relating to discrete income tax items.
  6. Adjusted Free Cash Flow for FY 21 is a projected Non-GAAP financial measure, is reconciled to projected GAAP Net Cash Provided by Operating
    Activities in the attached Reconciliation Schedules and / or in our November 5, 2020 earnings release in the "About Non-GAAP Financial Measures" section and is calculated based on projected Net Cash Provided by Operating Activities less projected capital expenditures.

I C R C o n f e r e n c e 2 0 2 1

Reconciliation Schedules

Organic Revenue Change

Three Months Ended September 30,

Six Months Ended September 30,

2020

2019

2020

2019

(In Thousands)

GAAP Total Revenues

$

237,422

$

238,069

$

466,816

$

470,223

Revenue Change

(0.3%)

(0.7%)

Adjustments:

Impact of foreign currency exchange rates

-

624

-

(729)

Total adjustments

$

-

$

624

$

-

$

(729)

Non-GAAP Organic Revenues

$

237,422

$

238,693

$

466,816

$

469,494

Non-GAAP Organic Revenue Change

(0.5%)

(0.6%)

Adjusted EPS

Three Months Ended September 30,

Six Months Ended September 30,

2020

2019

2020

2019

Net

Net

Net

Net

Income

EPS

Income

EPS

Income

EPS

Income

EPS

(In Thousands, except per share data)

GAAP Net Income

$

44,589

$

0.88

$

33,252

$

0.65

$

88,295

$

1.74

$

67,177

$

1.31

Adjustments:

Transition and other costs associated with new

warehouse in Cost of Goods Sold (a)

-

-

1,407

0.03

-

-

1,407

0.03

Tax impact of adjustments (b)

-

-

(344)

(0.01)

-

-

(344)

(0.01)

Normalized tax rate adjustment (c)

(5,106)

(0.10)

-

-

(5,106)

(0.10)

-

-

Total Adjustments

(5,106)

(0.10)

1,063

0.02

(5,106)

(0.10)

1,063

0.02

Non-GAAP Adjusted Net Income and Adjusted EPS

$

39,483

$

0.78

$

34,315

$

0.68

$

83,189

$

1.64

$

68,240

$

1.33

  1. Items related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during the transition.
  2. The income tax adjustments are determined using applicable rates in the taxing jurisdictions in which the above adjustments relate and includes both current and deferred income tax expense (benefit) based on the specific nature of the specific Non-GAAP performance measure.
  3. Income tax adjustment to adjust for discrete income tax items.

I C R C o n f e r e n c e 2 0 2 1

23

Reconciliation Schedules (Continued)

Adjusted EBITDA

  1. Items related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during the transition.

Adjusted Free Cash Flow

Three Months Ended September 30,

Six Months Ended September 30,

2020

2019

2020

2019

(In Thousands)

GAAP Net Income

$

44,589

$

33,252

$

88,295

$

67,177

Adjustments:

Adjustments to reconcile net income to net

cash provided by operating activities as shown in

the Statement of Cash Flows

11,374

14,039

29,775

28,896

Changes in operating assets and liabilities as shown in the

Statement of Cash Flows

(3,824)

2,932

9,223

6,927

Total adjustments

7,550

16,971

38,998

35,823

GAAP Net cash provided by operating activities

52,139

50,223

127,293

103,000

Purchase of property and equipment

(9,066)

(3,866)

(11,619)

(5,822)

Non-GAAP Free Cash Flow

43,073

46,357

115,674

97,178

Transition and other payments associated with new warehouse (a)

-

810

-

810

Non-GAAP Adjusted Free Cash Flow

$

43,073

$

47,167

$

115,674

$

97,988

I C R C o n f e r e n c e 2 0 2 1

24

Reconciliation Schedules (Continued)

Projected EPS

Projected FY'21 GAAP EPS

$

3.28

Adjustments:

Normalized tax rate adjustment for discrete income tax items (a)

(0.10)

Total Adjustments

(0.10)

Projected Non-GAAP Adjusted EPS

$

3.18

  1. Income tax adjustment to adjust for discrete income tax items.

Projected Free Cash Flow

(In millions)

Projected FY'21 GAAP Net Cash provided by operating activities

$

232

Additions to property and equipment for cash

(25)

Projected Non-GAAP Adjusted Free Cash Flow

$

207

I C R C o n f e r e n c e 2 0 2 1

25

I C R C o n f e r e n c e 2 0 2 1

Attachments

  • Original document
  • Permalink

Disclaimer

Prestige Consumer Healthcare Inc. published this content on 12 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2021 13:21:09 UTC